Smart Cancer Diagnostics from Austria Impresses in Italy

Product News   Nov 01, 2011

 
Smart Cancer Diagnostics from Austria Impresses in Italy
 
 
FURTHER INFORMATION
 
 
 

Related Product News

Cambridge Epigenetix Licenses Fundamental DNA Methylation IP from Boston Children’s Hospital

Product News

The exclusive licence enables the development and commercialisation of 5hmC technologies for epigenetic biomarker discovery.

READ MORE

A Simple, Sensitive Method to Detect Cancer-linked Transcription Factors

Product News

New fluorescent peptide imaging application of PXi System allows german researchers to easily detect leukaemia associated proteins.

READ MORE

OGT’s Expanded NGS Cancer Panels Enable Sequencing of Difficult Genes

Product News

New SureSeq myPanel™ NGS Custom Cancer Panel content covers a wider range of cancer types with excellent coverage uniformity for confident results.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics Microfluidics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE